Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to assess the safety and effectiveness of a nutraceutical supplement for the treatment of hair loss and thinning in females over the course of six months of continuous daily use.


Clinical Trial Description

This is a randomized, double-blind, placebo-controlled, study in adult female subjects with mild to moderate hair loss. Following an up to 35-day screening period to determine eligibility, subjects will be randomly assigned into one of the following treatment arms: Nutrafol® vs. Placebo. Nutrafol® or Placebo will randomly assigned be administered daily to the subjects for 6 months starting on Day 2. The subjects will return to the study site at Day 90 and Day 180 for assessments. Additionally, the subjects will return to the study site approximately 48 hours after Day 0 (Baseline Visit) and D180 in order to assess hair growth rate. Nutrafol® or Placebo will be dispensed by the non-blinded study staff with nonlabeled containers containing the corresponding tablets. Efficacy ratings will be performed by a trained investigator who will not be aware of the subject's treatment randomization in order to preserve double-blinding of the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03052413
Study type Interventional
Source Sadick Research Group
Contact
Status Completed
Phase N/A
Start date December 2016
Completion date November 10, 2017

See also
  Status Clinical Trial Phase
Withdrawn NCT05019066 - Oral Herbal Combination Formulation and Hair Growth in Women N/A
Recruiting NCT05502796 - Natural History and Pathogenesis of Alopecia in Children and Adults
Completed NCT00981461 - Treatment of Androgenetic Alopecia in Females, 9 Beam N/A
Terminated NCT03709563 - Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss N/A
Completed NCT06095739 - Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002 N/A
Completed NCT03351322 - ENERGI-F701 for Female Hair Loss Treatment Phase 2
Recruiting NCT06215469 - Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) N/A
Completed NCT05945979 - Evaluation of the Efficacy of a New Supplement for Hair and Nails - in Vitro, Clinical, Subjective and Instrumental Study N/A
Not yet recruiting NCT05484973 - Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss N/A
Recruiting NCT05319444 - Cleansing Device for the Treatment of Scalp and Hair Conditions N/A
Completed NCT06120933 - A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair Health N/A
Withdrawn NCT04379583 - HairDx Analytical Validation Study
Recruiting NCT05970809 - Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss N/A
Completed NCT00947219 - Treatment of Androgenic Alopecia in Males N/A
Not yet recruiting NCT03155958 - Ocular Finding in Alopecia Areata N/A
Enrolling by invitation NCT06174441 - The Effect of 24-week Dietary Intake of Food Supplements on Hair N/A
Unknown status NCT02393040 - Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia N/A
Completed NCT01016964 - Treatment of Androgenetic Alopecia in Females, 12 Beam N/A
Recruiting NCT06283316 - Systemic Treatments for Alopecia Areata Registry
Completed NCT04249128 - Nourishing Hair, Skin & Nails Supplement Study (Derm Aid) Phase 3